momandme_genomics

Mom&Me™

Comprehensive genetic screening for mom and newborn.

$2,698

One-Time Payment

Add to Cart

Testing Includes

  • Newborn analysis of 400+ genes through Whole Exome Sequencing.
  • Newborn risk assessment of 390 early-onset childhood diseases.
  • Interpretation of genes related to 650 actionable conditions that have an impact on mom.
  • Analysis of more than 200 conditions that can be passed on to future children.
  • Study of the mother's metabolism of more than 150 drugs.
  • Plus everything included in myNewborn and myGenome.

What's Included

What to Expect in the Mom&Me™ Genomic Screening

Mom&Me™ Genomic Screening is the most comprehensive screening option for your loved ones. Screen your newborn of nearly 400 genetic and hereditary conditions - providing key information for preventative management, diet, or even early treatment. Mom is covered too and is tested for nearly 1,000 clinical outcomes, carrier statuses, and more. With Mom&Me™ Genomic Screening, you’re unlocking the key to personalized medical management for your family. And by pairing it with Cord Blood Banking, no further blood draws are required.

Clinical Outcomes

Interpretations of 566 genes related to more than 650 conditions that may have a major impact on the mom's health. 

Early Screening

Whole exome sequencing and subsequent analysis of more than 400 genes related to more than 390 metabolic and genetic diseases of early childhood onset.

Autoimmune Disorders

Analysis of more than 200 conditions for which mom may be an asymptomatic carrier.

Pharmacogenomics

Study of genes related to metabolism, secondary targets and transporters to understand the effect of more than 150 drugs for mom.

Multifactorial Diseases

Complex pathologies that depend on genes and environment for mom.

Genetic Traits

Individual characteristics influenced by genes and environment for mom.

Ancestry

Analysis of DNA variants to establish the genetic origin of mom's ancestors.

Genetic Counseling

Certified Genetic Counselors available to help your family understand important finding.

Deep Dive

Why Invest in Genomic Screening?

asian-siblings_genomics
momandme-nursing_genomics

How it Works

Why is Genomic Screening for Mom and Baby Important?

Your genome is a resource for life. Mom&Me™ is for families who want to be proactive about their new family's health. 

Mom&Me™ gives insights on mom's risks for hereditary diseases in multiple categories including cancer, cardiovascular diseases, immune disorders, endocrine and matabolic disorders, neurological disorders, organ health, and more.

Mom&Me™ for baby is an extension of routine neonatal biochemical screening, increasing the number of metabolic and genetic diseases analyzed for intervention through nutrition or other procedures during early infancy, improving the health of the newborn.

momandme-laughing_genomics

Your Reports

What Can I Expect to Receive with Mom&Me™ Genomic Screening?

All families will receive a comprehensive report with detailed information about the variants detected and the implications for the newborn and mom. Families will have access to a trusted genetic counselor who will interpret and discuss the results.

Pathogenic variants and probably pathogenic variants classified based on American College of Medical Genetics and Genomics (ACMG) (PMID: 25741868) guidelines are reported.

GENOMIC SCREENING

Frequently Asked Questions

What is whole genome sequencing?

Whole genome sequencing is reading the billions of letters in your DNA, a long chain made up of As, Ts, Cs, and Gs. All your genes are encoded with this 4-letter code, so we analyze your sequence and subsequently look for changes or variants in the genes.

Why sequence the entire genome?

Whole genome sequencing allows all your genetic material to be read by creating a library about you. In this way you will be able to know the relevant information today to prevent and have access to updates in the future, accessing your library again. This trip makes it possible that from now on you can personalize, with the help of your specialist, your health care based on what makes you unique: your DNA.

How does genomic sequencing help my family?

Whole genome sequencing allows all your genetic material to be read by creating a library about you. In this way you will be able to know the relevant information today to prevent and have access to updates in the future, accessing your library again. This means that from now on you can personalize, with the help of your specialist, your health care based on what makes you unique: your DNA.

Why does pricing for genetic tests vary so much?

The cost of a genetic testing service is related to the technology utilized and the amount genetic expertise is required to provide the result. There is a direct correlation between the amount of DNA information analyzed and the more clinically impactful and reliable the result will be. At Americord, we use whole genome sequencing that allows for the capture and analyzing of all of a person’s DNA. Because the information is so valuable and can significantly impact a person’s future healthcare, we believe it should be managed by a medical professional. We support either directly or in collaboration with the prescribing physician the pre and post-test genetic counseling process where the results are explained and an action plan is established to fully benefit from the information provided.

Is Genomic Testing covered by my insurance?

No, genomic testing and/or screening is not covered by insurance companies in the United States. However, you may be able to use your FSA or HSA account(s) to cover the costs. 

Are there any states genomic services are not offered?

Yes, Alaska, California, New York, and Washington DC. These states have restrictions and regulations that prevent Americord from offering genomic services to individuals who have blood or saliva collected for genomic testing in these states.

If you are a resident of these restricted states, but deliver or provide a maternal blood outside of these states you can purchase Genomic services.